Article Details

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion - BioPharm International

Retrieved on: 2022-08-10 18:08:40

Tags for this article:

Click the tags to see associated articles and topics

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion - BioPharm International. View article details on hiswai:

Excerpt

Pfizer's $5.4 billion acquisition of Global Blood Therapeutics is expected to strengthen its sickle cell disease portfolio.

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up